Articles & Video
BioProcess International Fall Digital Week 2020
We explore the agenda for the upcoming BioProcess International Fall Digital Week 2020.
BioProcess International | BioProcess Insider
BioProcess International is a monthly, controlled-circulation magazine devoted to the development, scale-up, and manufacture of biotherapeutics and biodiagnostics.
Post-event Report: Cell & Gene Therapy Bioprocessing & Commercialization 2020
We review the key highlights from the virtual conference, including analysis of the hottest sessions by BioProcess International magazine.
Pharma’s role in maintaining cancer mortality progress during COVID-19
COVID-19 is threatening the progress made in reducing cancer mortality. Pharma has a pivotal role to play in helping patients and providers navigate the new reality of cancer treatment during the pandemic, and beyond.
TIDES Europe Virtual 2020: Post-event Report
This report looks back at the top sessions and features of this year's TIDES Europe Virtual.
BioProcess International 2020 Post-Event Report
Explore the highlights of the BioProcess International 2020 virtual conference in the post-event round-up.
Driving value in the era of biosimilars - What payers & manufacturers can do to support employers
We look at how big US employers are fostering broader adoption of biosimilar medications and what payers and manufacturers can do to support them.
Report: Partnering And Deal-Making in Pharma through the Pandemic
This Informa report explores how partnering and deal-making in the pharma industry has been impacted by COVID-19.
Ebook: The Future of the Cell and Gene Therapy Industry
What can we expect next from the cell and gene therapy sector? This ebook explores the potential paths ahead, from optimized CAR-T to automated bioprocessing.
Post-Event Report: Antibody Engineering and Therapeutics Europe 2020
Explore the highlights of Antibody Engineering & Therapeutics Europe Virtual 2020 in this post-event report.
When to outsource manufacturing? Advice for cell and gene therapy developers
What scenarios could determine when is best to outsource manufacturing of cell and gene therapies to a CDMO?
Advancing the Microbiome Therapeutics Industry
What more needs to be done to propel microbiome therapeutics towards safe, stable and commercialized production? This ebook reviews the story so far across regulations, standardization and technology.
REPORT: The Future of Healthcare Post COVID-19
In our latest report learn how healthcare organizations are adapting to succeed post COVID-19, from innovation to product development.
Vector manufacturing for cell and gene therapies: how should current platforms be changed?
What do we need from vector manufacturing platforms to deliver commercial scale therapies? We look at responses from industry insiders.
Novel analytical strategies and tools for cell and gene therapies - WHITEPAPER
What analytical techniques can be applied to production of cell therapies, gene therapies and gene-edited cell-therapies? This whitepaper looks at the latest examples.
Biosimilars Pipeline and Market Trends
Why is the US the most underdeveloped biosimilars market in the world? This BioProcess International eBook examines the trends.
Women in Pharma: 44% of pharma professionals think that women are under represented in their organization
44% of pharma professionals think that women are under represented in their organization according to new data from an Informa Connect Life Sciences study. Here we deep dive into the data.
Diversity and Inclusion in Biotech
The life science industry has a challenge to become more equal, diverse and inclusive. Join us at Diversity and Inclusion in Biotech, September 22nd and find out how TOGETHER we can make a difference.
SURVEY: Partnering and Deal-Making in Biopharma through the Pandemic
We are conducting a huge study to gauge perspectives around biopharma deal-making during COVID-19 and the commercial ramifications of the pandemic. Take part here.
Formulation, Fill, Finish - Biopharmaceutical Drug Products for a Modern Age
This BioProcess International eBook highlights drug-product formulation concerns and collaborative efforts toward solving the fill–finish conundrum.
Automating cell and gene therapy manufacturing: challenges and approaches
With the pressure on to scale up manufacturing of cell and gene therapies, what steps should organizations take to optimize their processes with automation? We asked three industry experts for their advice.